Literature DB >> 31520137

Effect of percutaneous endoscopic gastrojejunostomy tube placement on levodopa pharmacokinetics.

Noriyuki Miyaue1,2, Hayato Yabe3, Masahiro Nomoto4, Masahiro Nagai5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31520137     DOI： 10.1007/s00228-019-02762-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  Importance of within subject variation in levodopa pharmacokinetics: a 4 year cohort study in Parkinson's disease.

Authors:  Phylinda L S Chan; John G Nutt; Nicholas H G Holford
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

2.  Cascade stomach associated with delayed-on or no-on phenomenon in a patient with Parkinson's disease.

Authors:  Noriyuki Miyaue; Satoshi Tada; Rina Ando; Hayato Yabe; Noriko Nishikawa; Masahiro Nagai; Masahiro Nomoto
Journal:  Mov Disord       Date:  2017-08-07       Impact factor: 10.338

3.  Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes.

Authors:  Angelo Antonini; Ashley Yegin; Cornelia Preda; Lars Bergmann; Werner Poewe
Journal:  Parkinsonism Relat Disord       Date:  2014-12-19       Impact factor: 4.891

4.  Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.

Authors:  Hubert H Fernandez; James T Boyd; Victor S C Fung; Mark F Lew; Ramon L Rodriguez; John T Slevin; David G Standaert; Cindy Zadikoff; Arvydas D Vanagunas; Krai Chatamra; Susan Eaton; Maurizio F Facheris; Coleen Hall; Weining Z Robieson; Janet Benesh; Alberto J Espay
Journal:  Mov Disord       Date:  2018-03-23       Impact factor: 10.338

5.  Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results.

Authors:  Hubert H Fernandez; David G Standaert; Robert A Hauser; Anthony E Lang; Victor S C Fung; Fabian Klostermann; Mark F Lew; Per Odin; Malcolm Steiger; Eduard Z Yakupov; Sylvain Chouinard; Oksana Suchowersky; Jordan Dubow; Coleen M Hall; Krai Chatamra; Weining Z Robieson; Janet A Benesh; Alberto J Espay
Journal:  Mov Disord       Date:  2014-12-24       Impact factor: 10.338

6.  Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.

Authors:  Marianne Udd; Jukka Lyytinen; Johanna Eerola-Rautio; Anu Kenttämies; Outi Lindström; Leena Kylänpää; Eero Pekkonen
Journal:  Brain Behav       Date:  2017-06-05       Impact factor: 2.708
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.